Archive: Ross Marchand

Ross Marchand Ross Marchand is a Catalyst Policy Fellow and the director of policy for the Taxpayers Protection Alliance. He focuses on a range of issues, ranging from health-care reform to internet regulation to Postal Service-related issues. Ross is an alumnus of the Mercatus Center MA Fellowship at George Mason University, where he received his MA in economics in 2016. He has interned for the Texas Public Policy Foundation and the American Legislative Exchange Council, analyzing and blogging on a variety of public policy issues.
Andrew Yang’s Misguided Obsession with Automation
Acknowledging that there is room for improvement is different from kowtowing to a dystopian narrative based on zero evidence.
Ross Marchand | January 14, 2020
As Patients Enter New Decade, Obamacare Remains in the Rear View Mirror
By allowing more choice, policymakers can give patients a chance to enjoy this new year and many more to come.
Ross Marchand | January 10, 2020
Thanks to Crony Capitalism, Healthcare Competition Is Flatlining for Consumers
It’s time to end these crony practices and bring back some much-needed competition to the healthcare sector.
Ross Marchand | January 7, 2020
From the Russia Investigation to FBI Mass Surveillance, Government Snooping Is Out of Control
The best way to curb government malfeasance is by limiting the scope of warrants and surveillance in the first place.
Ross Marchand | January 3, 2020
Congress Must Axe Christmas Tree Tax
The Consumer Product Safety Commission has been having a field day regulating any and all festive lights under Santa’s sleigh.
Ross Marchand | December 23, 2019
An Alzheimer’s Cure May Be On the Horizon—But Only With Right-Sized Regulations
The FDA could and should be more open-minded in evaluating the evidence in its drug approval decisions.
Ross Marchand | December 16, 2019
An International Agency Could Erode American Liberties on U.S. Taxpayers’ Dime
Attorney-client privilege is a cornerstone of Western law and is worth preserving.
Ross Marchand | December 6, 2019
Did Midas Touch Medicare?
Despite its positive reputation, Medicare isn’t exactly a harbinger of health.
Ross Marchand | November 22, 2019
A Tale of Two Drug Approvals
The FDA has a unique responsibility to approve game-changing medications in a timely manner.
Ross Marchand | November 15, 2019
Germany Shows Universal Healthcare Is No Panacea
The government mandates, standardizes, and subsidizes care, and yet, struggling citizens still get subpar care.
Ross Marchand | November 5, 2019